Teladoc Health (TDOC) just gave investors reason to rethink the turnaround story. Shares plunged more than 28% on July 30 after the company reported its second-quarter results and cut its full-year revenue outlook. TDOC stock had been gaining momentum earlier this year, but the latest report brought the BetterHelp problem back into focus.
The question now is whether this selloff creates an attractive entry point — or signals that Teladoc's recovery will take longer than investors previously expected. Let's take a closer look.